De Vecchis, R.
Ariano, C.
Di Biase, G.
Noutsias, M.
Article History
Received: 27 December 2017
Revised: 18 January 2018
Accepted: 18 January 2018
First Online: 15 February 2018
Compliance with ethical guidelines
:
: R. DeVecchis, C. Ariano, and G. DiBiase declare that they have no competing interests. M. Noutsias has received grants from the Deutsche Forschungsgemeinschaft (DFG) through the Sonderforschungsbereich Transregio 19 “Inflammatory Cardiomyopathy” (SFB TR19) (TP B2), and by the University Hospital Giessen and Marburg Foundation Grant “T Cell Functionality” (UKGM 10/2009). M. Noutsias has been consultant to the IKDT (Institute for Cardiac Diagnosis and Therapy GmbH, Berlin) 06/2004-06/2008, and has received honoraria for presentations and/or participated in advisory boards from AstraZeneca, Bayer, Boehringer Ingelheim, Fresenius, Miltenyi Biotech, Novartis, Pfizer, and Zoll.
: This article does not contain any studies with human participants or animals performed by any of the authors.